4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Genscript Biotech Corporation (1548) operates in the Biotechnology industry and is headquartered in Wan Chai, Hong Kong with about 6,165 employees. Its market capitalization is roughly $54 billion. In the fiscal year ended 2025-12-31, 1548 reported $960M in revenue and ($533M) in net income.
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $960M | $594M | $560M | $626M |
| Gross Profit | $553M | $272M | $271M | $304M |
| Operating Income (EBIT) | $262M | $23M | $40M | ($428M) |
| Net Income | ($533M) | $3.0B | ($96M) | ($227M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $4.9B | $5.3B | $3.4B | $2.5B | — |
| Total Liabilities | $889M | $955M | $1.3B | $1.2B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1548 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms